Cargando…

Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura

Following an acute thrombotic thrombocytopenic purpura (TTP) episode, patients are at risk for relapse, and a careful long-term follow-up is needed. Adherence to the follow-up by patients implies a good understanding of the disease. However, TTP literacy in patients is currently unknown. To explore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Leydi C. Velasquez, Ercig, Bogac, Kangro, Kadri, Jamme, Matthieu, Malot, Sandrine, Galicier, Lionel, Poullin, Pascale, Provôt, François, Presne, Claire, Kanouni, Tarik, Servais, Aude, Benhamou, Ygal, Daguindau, Nicolas, Vanhoorelbeke, Karen, Azoulay, Elie, Veyradier, Agnès, Coppo, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430230/ https://www.ncbi.nlm.nih.gov/pubmed/32885148 http://dx.doi.org/10.1097/HS9.0000000000000462

Ejemplares similares

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura
por: Graça, Nuno A. G., et al.
Publicado: (2019)

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura
por: Roriz, Mélanie, et al.
Publicado: (2015)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2018)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2021)

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors
por: Martino, Suella, et al.
Publicado: (2016)

Preemptive cyclosporin A in immune‐mediated thrombotic thrombocytopenic purpura
por: Comparon, Celine, et al.
Publicado: (2022)

More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura
por: Picod, Adrien, et al.
Publicado: (2022)

Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura
por: Stubbs, Matthew J., et al.
Publicado: (2021)

Immune‐mediated thrombotic thrombocytopenic purpura prognosis is affected by blood pressure
por: Joseph, Adrien, et al.
Publicado: (2022)

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
por: Picod, Adrien, et al.
Publicado: (2022)

ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology
por: Joly, Bérangère S., et al.
Publicado: (2022)

The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2023)

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome
por: Jamme, Matthieu, et al.
Publicado: (2017)

Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity
por: Tellier, Edwige, et al.
Publicado: (2022)

Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
por: Schelpe, An-Sofie, et al.
Publicado: (2019)

Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
por: Beranger, Nicolas, et al.
Publicado: (2020)

Tuberculosis associated thrombocytopenic purpura: effectiveness of antituberculous therapy
por: Borie, Raphael, et al.
Publicado: (2009)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Predictive Scores for Early Identification of Immune-Mediated Thrombotic Thrombocytopenic Purpura: Room for Improvement?
por: Joseph, Adrien, et al.
Publicado: (2022)

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease
por: Delmas, Yahsou, et al.
Publicado: (2015)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
por: Kangro, Kadri, et al.
Publicado: (2020)

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
por: Coppo, Paul, et al.
Publicado: (2010)

HLA-DRB1*11 is a strong risk factor for acquired thrombotic thrombocytopenic purpura in children
por: Joly, Bérangère S., et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine
por: Coppo, Paul, et al.
Publicado: (2018)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Update – PROFILE: Early-Stage Researchers Advancing Insights on TTP through a Unique PhD Track
por: Vanhoorelbeke, Karen, et al.
Publicado: (2019)

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
por: Arıkan, Fatma, et al.
Publicado: (2020)

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation and New ADAMTS 13 Mutation in a Tunisian Child
por: Borgi, A., et al.
Publicado: (2013)

Idiopathic thrombocytopenic purpura
por: Kayal, L., et al.
Publicado: (2014)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Immune thrombocytopenic purpura
por: Zainal, Abir, et al.
Publicado: (2019)

Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome
por: Mouabbi, Jason Aboudi, et al.
Publicado: (2016)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
por: Sakai, Kazuya, et al.
Publicado: (2022)

Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Dupuy, Henry, et al.
Publicado: (2018)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Octaploidy in idiopathic thrombocytopenic purpura
por: Makroo, R. N., et al.
Publicado: (2011)

Drug-induced thrombocytopenic purpura
por: Sathiasekar, Anisha Cynthia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2hp08jr7h2gfmql1k623rg8mb9